PPA
PMVP icon

Parametric Portfolio Associates’s PMV Pharmaceuticals PMVP Stock Holding History

Parametric Portfolio Associates’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$969K Buy
46,528
+15,110
+48% +$267K ﹤0.01% 2795
2021
Q4 		$726K Buy
31,418
+3,273
+12% +$79.1K ﹤0.01% 2923
2021
Q3 		$839K Buy
28,145
+5,482
+24% +$175K ﹤0.01% 2878
2021
Q2 		$774K Buy
22,663
+1,694
+8% +$56.6K ﹤0.01% 2888
2021
Q1 		$690K Buy
20,969
+2,855
+16% +$113K ﹤0.01% 3335
2020
Q4 		$1.11M Buy
18,114
+7,351
+68% +$288K ﹤0.01% 2989
2020
Q3 		$382K Buy
+10,763
New +$396K ﹤0.01% 3381

Other funds holding PMVP

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return